...
首页> 外文期刊>Open Pharmaceutical Sciences Journal >Extended Release of Timolol from Ethyl Cellulose Microparticles Laden Hydrogel Contact Lenses
【24h】

Extended Release of Timolol from Ethyl Cellulose Microparticles Laden Hydrogel Contact Lenses

机译:乙基纤维素微粒载有水凝胶隐形眼镜的替莫洛尔的缓释

获取原文
           

摘要

Glaucoma is a second leading cause of blindness globally after cataract, which is managed through eye drops, which are highly inefficient due to a low bioavailability of less than 1-5%. Frequent administration of eye drops leads to incompliance in patients, so there is a great need for medical device such as contact lenses to treat glaucoma. The objective of research was to provide sustained ocular delivery of timolol via prototype poly (hydroxyethyl methacrylate) hydrogel contact lenses which may improve bioavailability due to increase in ocular residence time of drug. The present work was to encapsulate drug in ethylcellulose microparticles, and to entrap these microparticles in the hydrogel. Microparticles were prepared by spray drying method using different ratios of drug to ethylcellulose. The solid state characterization studies of drug loaded microparticles revealed the transformation of drug to an amorphous state. The hydrogels were characterized by studying their optical and physical properties to determine their suitability as extended wear contact lenses. Microparticles laden hydrogels were compared with direct drug loaded hydrogels. The study of microparticles laden hydrogels showed reduction in optical and physical properties and the impact was proportional to the amount of microparticles in hydrogels. The results suggest the application of optimization and nanotechnology. In vitro drug release study revealed that direct loading batch delivers drug for 22 hours with high drug loading of 150 μg, while microparticles laden hydrogel deliver drug up to 48 hours (zero order kinetics) with low drug loading of 50 μg. The hydrogels appeared safe in the cytotoxicity study. The study demonstrated the promising potential of loading the ethyl cellulose microparticles into hydrogels to serve as a good platform for sustained ophthalmic drug delivery.
机译:青光眼是白内障之后全球失明的第二个主要诱因,这是通过滴眼药水进行管理的,由于低的生物利用度(低于1%至5%),滴眼药水的效率极低。频繁滴眼药水会导致患者不适应,因此迫切需要诸如隐形眼镜之类的医疗设备来治疗青光眼。研究的目的是通过原型聚(甲基丙烯酸羟乙酯)水凝胶隐形眼镜提供噻吗洛尔的持续眼部递送,这可能由于药物在眼部停留时间的增加而提高了生物利用度。目前的工作是将药物封装在乙基纤维素微粒中,并将这些微粒截留在水凝胶中。使用不同比例的药物与乙基纤维素,通过喷雾干燥法制备微粒。载有药物的微粒的固态表征研究表明,药物已转变为无定形状态。通过研究其光学和物理特性来确定水凝胶的特性,以确定其是否适合长时间佩戴隐形眼镜。将载有微粒的水凝胶与直接载药的水凝胶进行比较。载有微粒的水凝胶的研究表明,其光学和物理性能下降,并且其影响与水凝胶中微粒的数量成正比。结果表明优化技术和纳米技术的应用。体外药物释放研究表明,直接装载分批可在150克的高载药量下递送药物22小时,而载有微粒的水凝胶可在50克的低载药量下最多递送48小时(零级动力学)。水凝胶在细胞毒性研究中似乎是安全的。该研究证明了将乙基纤维素微粒装载到水凝胶中作为潜在的眼科药物持续输送的良好平台的潜在潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号